Free Trial

Acurx Pharmaceuticals (ACXP) Short Interest Ratio & Short Volume

Acurx Pharmaceuticals logo
$0.41 0.00 (-0.77%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$0.43 +0.02 (+4.62%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Acurx Pharmaceuticals Short Interest Data

Acurx Pharmaceuticals (ACXP) has a short interest of 353,000 shares, representing 1.81% of the float (the number of shares available for trading by the public). This marks a -15.73% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.5, indicating that it would take 1.5 days of the average trading volume of 164,669 shares to cover all short positions.

Current Short Interest
353,000 shares
Previous Short Interest
418,900 shares
Change Vs. Previous Month
-15.73%
Dollar Volume Sold Short
$151,790.00
Short Interest Ratio
1.5 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
23,482,000 shares
Float Size
19,450,000 shares
Short Percent of Float
1.81%
Today's Trading Volume
156,570 shares
Average Trading Volume
164,669 shares
Today's Volume Vs. Average
95%
Short Selling Acurx Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ACXP Short Interest Over Time

ACXP Days to Cover Over Time

ACXP Percentage of Float Shorted Over Time

Acurx Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2025353,000 shares $151,790.00 -15.7%1.8%1.5 $0.43
4/15/2025418,900 shares $159,182.00 -11.9%2.2%1.7 $0.38
3/31/2025475,600 shares $185,484.00 +12.2%2.5%1.3 $0.39
3/15/2025423,800 shares $195,371.80 -6.4%2.2%1.2 $0.46
2/28/2025452,800 shares $321,261.60 +112.2%2.7%1.3 $0.71
2/15/2025213,400 shares $158,342.80 -31.8%1.3%0.6 $0.74
1/31/2025313,100 shares $228,750.86 -52.2%1.9%1.2 $0.73
1/15/2025655,000 shares $471,534.50 +41.9%4.0%2.5 $0.72
12/31/2024461,600 shares $375,742.40 -8.1%2.8%2.2 $0.81
12/15/2024502,100 shares $429,345.71 +8.2%3.5%4 $0.86
11/30/2024463,900 shares $579,875.00 +4.6%3.2%4.1 $1.25
11/15/2024443,700 shares $763,164.00 -6.5%3.1%5.9 $1.72
10/31/2024474,500 shares $892,060.00 -5.5%3.4%10.1 $1.88
10/15/2024501,900 shares $1.02 million +2.1%3.6%10.2 $2.04
9/30/2024491,700 shares $934,230.00 +2.8%3.6%7.6 $1.90
9/15/2024478,300 shares $975,732.00 +5.6%3.5%7.8 $2.04
8/31/2024452,800 shares $996,160.00 +3.1%3.3%7.7 $2.20
8/15/2024439,400 shares $896,376.00 -5.4%3.2%8.1 $2.04
7/31/2024464,300 shares $1.00 million -17.3%3.5%7.8 $2.16
7/15/2024561,200 shares $1.34 million -8.6%4.2%9.4 $2.39
6/30/2024614,100 shares $1.38 million -7.1%4.6%10.9 $2.25
6/15/2024661,200 shares $1.61 million -4.0%4.9%10.6 $2.43
5/31/2024688,400 shares $1.73 million +15.6%5.1%9.2 $2.51
5/15/2024595,600 shares $1.34 million -3.2%4.4%7.4 $2.25
4/30/2024615,500 shares $1.38 million +6.3%4.7%7.4 $2.25
4/15/2024579,100 shares $946,828.50 +71.6%4.8%5.6 $1.64
3/31/2024337,400 shares $826,630.00 +14.6%2.8%2 $2.45
3/15/2024294,500 shares $801,040.00 +0.9%2.5%1.7 $2.72
2/29/2024291,900 shares $837,753.00 -3.2%2.6%1.3 $2.87
2/15/2024301,500 shares $919,575.00 -12.3%2.7%1.3 $3.05
1/31/2024343,700 shares $1.12 million +41.1%3.0%1.4 $3.27
1/15/2024243,600 shares $1.13 million -18.5%2.1%0.7 $4.63
12/31/2023298,800 shares $1.14 million -32.0%2.6%0.5 $3.83
12/15/2023439,100 shares $1.54 million -21.0%3.9%0.5 $3.50
11/30/2023555,800 shares $1.96 million -14.3%5.0%0.7 $3.52
11/15/2023648,300 shares $2.23 million -31.5%5.8%0.9 $3.44
10/31/2023946,100 shares $5.06 million -9.0%9.0%1.3 $5.35
10/15/20231,040,000 shares $4.51 million +10,197.0%9.9%1.6 $4.34
9/30/202310,100 shares $15,150.00 +50.8%0.1%0 $1.50
9/15/20236,700 shares $11,859.00 -51.1%0.1%0.2 $1.77
Warning: Prepare to Be Shocked by These Payouts (Ad)

There's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don't even pay dividends. It's fast, it's legal, and most people have no clue it exists.

Click here to see how much you could be collecting each month →
8/31/202313,700 shares $26,441.00 +95.7%0.1%0.4 $1.93
8/15/20237,000 shares $11,200.00 -63.0%0.1%0.2 $1.60
7/31/202318,900 shares $38,367.00 +42.1%0.2%0.7 $2.03
7/15/202313,300 shares $28,462.00 +58.3%0.1%0.5 $2.14
6/30/20238,400 shares $22,260.00 -27.6%0.1%0.3 $2.65
6/15/202311,600 shares $31,900.00 +39.8%0.1%0.5 $2.75
5/31/20238,300 shares $25,730.00 -60.9%0.1%0.3 $3.10
5/15/202321,200 shares $71,868.00 -7.0%0.2%0.7 $3.39
4/30/202322,800 shares $68,172.00 +4.1%0.3%0.7 $2.99
4/15/202321,900 shares $64,824.00 -25.5%0.2%0.7 $2.96
3/31/202329,400 shares $101,724.00 -52.8%0.3%0.9 $3.46
3/15/202362,300 shares $212,443.00 +150.2%0.7%1.8 $3.41
2/28/202324,900 shares $82,419.00 -33.8%0.3%0.7 $3.31
2/15/202337,600 shares $131,976.00 +78.2%0.4%1.2 $3.51
1/31/202321,100 shares $75,960.00 -7.9%0.2%0.7 $3.60
1/15/202322,900 shares $97,325.00 -3.4%0.2%0.9 $4.25
12/30/202223,700 shares $94,326.00 -18.0%0.3%1 $3.98
12/15/202228,900 shares $112,710.00 +26.8%0.3%1.4 $3.90
11/30/202222,800 shares $72,732.00 -1.3%0.2%1 $3.19
11/15/202223,100 shares $72,072.00 +5.5%0.3%1 $3.12
10/31/202221,900 shares $67,452.00 -27.2%0.2%0.8 $3.08
10/15/202230,100 shares $88,795.00 -22.2%0.3%1.1 $2.95
9/30/202238,700 shares $116,100.00 +45.5%0.4%1.5 $3.00
9/15/202226,600 shares $103,740.00 +10.8%0.3%1 $3.90
8/31/202224,000 shares $83,760.00 -34.1%0.3%0.9 $3.49
8/15/202236,400 shares $164,164.00 -13.5%0.4%1.6 $4.51
7/31/202242,100 shares $150,718.00 +89.6%0.5%2.1 $3.58
7/15/202222,200 shares $80,475.00 -43.9%N/A1.4 $3.63
6/30/202239,600 shares $150,084.00 -29.9%N/A2.5 $3.79
6/15/202256,500 shares $213,570.00 +16.3%N/A3.2 $3.78
5/31/202248,600 shares $130,734.00 -1.2%N/A2.8 $2.69
5/15/202249,200 shares $133,332.00 +39.4%N/A2.7 $2.71
4/30/202235,300 shares $131,669.00 -59.2%N/A2 $3.73
4/15/202286,600 shares $346,400.00 -22.3%N/A3.3 $4.00
3/31/2022111,400 shares $365,392.00 +136.5%N/A4 $3.28
3/15/202247,100 shares $175,683.00 +9.0%N/A1.6 $3.73
2/28/202243,200 shares $157,209.12 -53.7%N/A1.4 $3.64
2/15/202293,300 shares $375,999.00 -4.3%N/A2.6 $4.03
1/31/202297,500 shares $405,600.00 -28.8%N/A2.3 $4.16
1/15/2022137,000 shares $627,460.00 -16.2%N/A3 $4.58
12/31/2021163,400 shares $706,116.76 -6.0%N/A3.6 $4.32
12/15/2021173,800 shares $716,056.00 +52.2%N/A2.9 $4.12
11/30/2021114,200 shares $548,160.00 -17.1%N/A1.9 $4.80
11/15/2021137,700 shares $684,369.00 +14.9%N/A2.2 $4.97
10/29/2021119,800 shares $599,000.00 +17.7%N/A1.7 $5.00
10/15/2021101,800 shares $499,838.00 -4.9%N/A1.2 $4.91
9/30/2021107,000 shares $549,980.00 +11.2%N/A0.8 $5.14
9/15/202196,200 shares $485,810.00 +24.9%N/A0.2 $5.05
8/31/202177,000 shares $398,090.00 -35.9%N/A0.1 $5.17
8/13/2021120,100 shares $576,480.00 No ChangeN/A0.1 $4.80
AI Meltdown Imminent: Dump These Stocks Now! (Ad)

If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.

Click here to see the details and learn how to prepare for the next AI revolution

ACXP Short Interest - Frequently Asked Questions

What is Acurx Pharmaceuticals' current short interest?

Short interest is the volume of Acurx Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 353,000 shares of ACXP short. 1.81% of Acurx Pharmaceuticals' shares are currently sold short. Learn More on Acurx Pharmaceuticals' current short interest.

What is a good short interest ratio for Acurx Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACXP shares currently have a short interest ratio of 2.0. Learn More on Acurx Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Acurx Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.81% of Acurx Pharmaceuticals' floating shares are currently sold short.

Is Acurx Pharmaceuticals' short interest increasing or decreasing?

Acurx Pharmaceuticals saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 353,000 shares, a decrease of 15.7% from the previous total of 418,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Acurx Pharmaceuticals' float size?

Acurx Pharmaceuticals currently has issued a total of 23,482,000 shares. Some of Acurx Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acurx Pharmaceuticals currently has a public float of 19,450,000 shares.

How does Acurx Pharmaceuticals' short interest compare to its competitors?

1.81% of Acurx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Acurx Pharmaceuticals: NRx Pharmaceuticals, Inc. (8.47%), Rani Therapeutics Holdings, Inc. (10.31%), Aligos Therapeutics, Inc. (20.79%), Spero Therapeutics, Inc. (1.15%), LAVA Therapeutics (0.81%), Akari Therapeutics, Plc (0.42%), Coeptis Therapeutics Holdings, Inc. (2.14%), FibroBiologics, Inc. (5.36%), Dyadic International, Inc. (0.48%), bluebird bio, Inc. (4.42%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Acurx Pharmaceuticals stock?

Short selling ACXP is an investing strategy that aims to generate trading profit from Acurx Pharmaceuticals as its price is falling. ACXP shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Acurx Pharmaceuticals?

A short squeeze for Acurx Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACXP, which in turn drives the price of the stock up even further.

How often is Acurx Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACXP, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:ACXP) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners